title: The next revolution: percutaneous aortic valve replacement.
abstract: Aortic valve replacement (AVR) is a treatment of choice for patients with symptomatic severe aortic stenosis (AS). However, a significant proportion of these patients do not undergo surgical AVR due to high-risk features. Transcatheter aortic valve implantation (TAVI) has emerged as an alternative for patients with severe AS who are not candidates for open-heart surgery. Since the introduction of TAVI to the medical community in 2002, there has been an explosive growth in procedures. The balloon-expandable Edwards SAPIEN valve and the self-expanding CoreValve ReValving(TM) system contribute the largest patient experience with more than 10,000 patients treated with TAVI to date. Clinical outcomes have stabilized in experienced hands, with 30-day mortality less than 10%. Careful patient selection, growing operator experience, and an integrated multidisciplinary team approach contribute to notable improvement in outcomes. In the first randomized pivotal PARTNER trial, in patients with severe AS not suitable candidates for surgical AVR, TAVI compared with standard therapy, significantly improved survival and cardiac symptoms, but was associated with higher incidence of major strokes and major vascular events. The results of randomized comparison of TAVI with AVR among high-risk patients with AS for whom surgery is a viable option are eagerly awaited to provide further evidence on the applicability of TAVI in these patients.
authors.affiliation: Professor of Medicine, Columbia University College of Physicians and Surgeons, Associate Director, Center for Interventional Vascular Therapy, New York-Presbyterian Hospital/Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY, USA;
authors.forename: Martin B
authors.initials: MB
authors.lastname: Leon
authors.forename: Eugenia
authors.initials: E
authors.lastname: Nikolsky
keywords: Aortic valve; percutaneous; transcatheter
references.citation: JACC Cardiovasc Interv. 2009 Sep;2(9):821-7
references.pmid: 19778769
references.citation: N Engl J Med. 2010 Oct 21;363(17):1597-607
references.pmid: 20961243
references.citation: Circulation. 2007 Sep 11;116(11 Suppl):I240-5
references.pmid: 17846311
references.citation: Catheter Cardiovasc Interv. 2009 Dec 1;74(7):1116-9
references.pmid: 19626691
references.citation: J Heart Valve Dis. 1995 Oct;4 Suppl 2:S194-7
references.pmid: 8563997
references.citation: Circulation. 2007 Aug 14;116(7):755-63
references.pmid: 17646579
references.citation: J Am Coll Cardiol. 2006 Mar 21;47(6):1214-23
references.pmid: 16545654
references.citation: Circulation. 2008 Oct 7;118(15):e523-661
references.pmid: 18820172
references.citation: EuroIntervention. 2008 Aug;4(2):242-9
references.pmid: 19110790
references.citation: Circulation. 2002 Dec 10;106(24):3006-8
references.pmid: 12473543
references.citation: J Am Coll Cardiol. 2004 Oct 6;44(7):1467-72
references.pmid: 15464329
references.citation: Lancet. 2006 Sep 16;368(9540):1005-11
references.pmid: 16980116
references.citation: EuroIntervention. 2008 Nov;4(3):351-7
references.pmid: 19110809
references.citation: Ann Thorac Surg. 2008 Jul;86(1):46-54; discussion 54-5
references.pmid: 18573397
references.citation: Eur Heart J. 2010 Apr;31(7):865-74
references.pmid: 20037180
references.citation: Heart. 2003 Nov;89(11):1316-21
references.pmid: 14594888
references.citation: Br Heart J. 1973 Jan;35(1):41-6
references.pmid: 4685905
references.citation: Circulation. 1968 Jul;38(1 Suppl):61-7
references.pmid: 4894151
references.citation: Catheter Cardiovasc Interv. 2010 Sep 1;76(3):450-4
references.pmid: 20552651
references.citation: J Am Coll Cardiol. 2009 May 19;53(20):1829-36
references.pmid: 19442881
references.citation: Eur Heart J. 2003 Jul;24(13):1231-43
references.pmid: 12831818
references.citation: Circ Cardiovasc Interv. 2008 Dec;1(3):167-75
references.pmid: 20031675
references.citation: J Thorac Cardiovasc Surg. 2011 Feb;141(2):487-91, 491.e1
references.pmid: 20434180
references.citation: JACC Cardiovasc Interv. 2008 Jun;1(3):305-9
references.pmid: 19463318
references.citation: J Am Coll Cardiol. 2009 Jul 21;54(4):303-11
references.pmid: 19608027
references.citation: Circulation. 2006 Oct 10;114(15):1616-24
references.pmid: 17015786
references.citation: EuroIntervention. 2010 May;6(1):100-5
references.pmid: 20542804
references.citation: Circulation. 1982 Nov;66(5):1105-10
references.pmid: 7127696
references.citation: Catheter Cardiovasc Interv. 2010 Jun 1;75(7):1129-36
references.pmid: 20146328
references.citation: Circulation. 2009 Jun 16;119(23):3009-16
references.pmid: 19487594
references.citation: J Am Coll Cardiol. 2011 Jan 18;57(3):253-69
references.pmid: 21216553
references.citation: Arch Mal Coeur Vaiss. 2007 Nov;100(11):901, 904-8
references.pmid: 18209690
references.citation: J Am Coll Cardiol. 2004 Feb 18;43(4):698-703
references.pmid: 14975485
references.citation: J Am Coll Cardiol. 2010 Apr 6;55(14):1427-32
references.pmid: 20188503
references.citation: Am Heart J. 2010 Mar;159(3):497-503
references.pmid: 20211315
references.citation: Circulation. 2010 Feb 23;121(7):870-8
references.pmid: 20177005
references.citation: Catheter Cardiovasc Interv. 2009 Apr 1;73(5):713-6
references.pmid: 19180656
references.citation: J Am Coll Cardiol. 2009 May 19;53(20):1883-91
references.pmid: 19442889
references.citation: J Am Coll Cardiol. 2001 Jul;38(1):163-6
references.pmid: 11451267
references.citation: Artif Organs. 2000 Dec;24(12):953-8
references.pmid: 11121975
references.citation: Circulation. 2006 Feb 14;113(6):842-50
references.pmid: 16461813
references.citation: Lancet. 2000 Oct 21;356(9239):1403-5
references.pmid: 11052583
references.citation: J Am Coll Cardiol. 2007 Jul 3;50(1):69-76
references.pmid: 17601548